The gold standards of treatment for ADHD are the stimulants amphetamine and methylphenidate. They are old friends, having been used for decades, and there is a wealth of patient experience with them. Although we use them all the time, an occasional review of the tools in our toolbox is always helpful.

Neurofeedback, also known as “EEG biofeedback,” has been around for a long time, but its history is checkered.

At a certain point [in my research career], with all the children and adolescents who were being prescribed psychiatric medications, I thought that the adverse effects of antipsychotics in this young patient population were worth examining.

Researchers have often found an association between television viewing and higher rates of attention problems over time, though not all studies have supported this link.

I first met Christina when she was 14. She had been diagnosed with borderline personality disorder and bipolar disorder.

As the clinical director of the Institute for Learning and Academic Achievement, I evaluate children and teens for learning disabilities, developmental disabilities, and neuropsychological impairments, including ADHD. We work toward understanding the ways children learn and helping them pursue academic endeavors and overcome barriers that get in their ways.

Studies of “treatment as usual” in outpatient child and adolescent psychiatry settings are hard to come by.

Historically, research into the effectiveness of antidepressants for depressed youths has been unimpressive. The history of SSRI use in children has been fraught with its own series of disappointments and controversies.

The extent to which antidepressants are effective for pediatric depression continues to stir controversy, as discussed in this issue of CCPR.

Depression in teenagers can present quite differently from both adults and younger kids. Can you help us to understand how to go about diagnosing depression in teens?